Alpha 2.0
Login Register
» Articles » PMID: 18391919

Review: Hepatotoxicity and EGFR Inhibition

Overview
Journal Clin Adv Hematol Oncol
Specialty Hematology
Date 2008 Apr 9
PMID 18391919
Citations 4
Authors
Jeyanthi Ramanarayanan
Ganapathy S Krishnan
Affiliations
Soon will be listed here.
Citing Articles

Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer.

Vigano M, La Milia M, Grassini M, Pugliese N, De Giorgio M, Fagiuoli S Cancers (Basel). 2023; 15(6).

PMID: 36980652 PMC: 10046041. DOI: 10.3390/cancers15061766.

Metabolic Forest: Predicting the Diverse Structures of Drug Metabolites.

Hughes T, Dang N, Kumar A, Flynn N, Swamidass S J Chem Inf Model. 2020; 60(10):4702-4716.

PMID: 32881497 PMC: 8716321. DOI: 10.1021/acs.jcim.0c00360.

Computational explanation for bioactivation mechanism of targeted anticancer agents mediated by cytochrome P450s: A case of Erlotinib.

Ai C, Liu Y, Li W, Chen D, Zhu X, Yan Y PLoS One. 2017; 12(6):e0179333.

PMID: 28628631 PMC: 5476264. DOI: 10.1371/journal.pone.0179333.

Metabolism considerations for kinase inhibitors in cancer treatment.

Duckett D, Cameron M Expert Opin Drug Metab Toxicol. 2010; 6(10):1175-93.

PMID: 20684746 PMC: 2940961. DOI: 10.1517/17425255.2010.506873.